These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 39550833)
1. Gq/G11 oncogenic mutations promote PD-L1 expression and suppress tumor immunity. Dong J; Xu Y; Yu D; Zhang X; Wang A; Lv L; Li Z Eur J Cell Biol; 2024 Dec; 103(4):151467. PubMed ID: 39550833 [TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA sequencing reveals key molecular drivers and immune landscape in uveal melanoma: implications for targeted therapy and prognostic modeling. Song Z; Shao W; Xiahou Z; Xu Y; Zhang X Front Immunol; 2024; 15():1493752. PubMed ID: 39635521 [TBL] [Abstract][Full Text] [Related]
3. Cannabidiol Enhances Atezolizumab Efficacy by Upregulating PD-L1 Expression via the cGAS-STING Pathway in Triple-Negative Breast Cancer Cells. Kim BG; Kim BR; Kim DY; Kim WY; Kang S; Lee SI; Oh SC Cancer Immunol Res; 2024 Dec; 12(12):1796-1807. PubMed ID: 39226389 [TBL] [Abstract][Full Text] [Related]
4. The BET inhibitor JQ1 suppresses tumor survival by ABCB5-mediated autophagy in uveal melanoma. Liu W; Cui Z; Wan Q; Liu Y; Chen M; Cheng Y; Sang X; Su Y; Gu S; Li C; Liu C; Chen S; Wang Z; Wang X Cell Signal; 2025 Jan; 125():111483. PubMed ID: 39442901 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
7. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis. Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741 [TBL] [Abstract][Full Text] [Related]
8. Spatially Resolved Whole-Transcriptomic and Proteomic Profiling of Lung Cancer and Its Immune Microenvironment According to PD-L1 Expression. Koh J; Lee D; Kim S; Song SG; Han B; Jeong H; Kim YA; Keam B; Lee SH; Kim K; Jeon YK; Chung DH Cancer Immunol Res; 2024 Dec; 12(12):1753-1764. PubMed ID: 39235761 [TBL] [Abstract][Full Text] [Related]
9. Australia in 2030: what is our path to health for all? Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362 [TBL] [Abstract][Full Text] [Related]
10. XIAOPI formula inhibits chemoresistance and metastasis of triple-negative breast cancer by suppressing extracellular vesicle/CXCL1-induced TAM/PD-L1 signaling. Wang S; Xu S; Li J; Wang N; Zheng Y; Wang Z Phytomedicine; 2024 Dec; 135():156039. PubMed ID: 39303510 [TBL] [Abstract][Full Text] [Related]
11. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication. Ryan R; Hill S Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081 [TBL] [Abstract][Full Text] [Related]
12. Identification of Functional Immune Biomarkers in Breast Cancer Patients. Derakhshandeh R; Zhu Y; Li J; Hester D; Younis R; Koka R; Jones LP; Sun W; Goloubeva O; Tkaczuk K; Bates J; Reader J; Webb TJ Int J Mol Sci; 2024 Nov; 25(22):. PubMed ID: 39596374 [TBL] [Abstract][Full Text] [Related]
13. Dynamic Field Theory of Executive Function: Identifying Early Neurocognitive Markers. McCraw A; Sullivan J; Lowery K; Eddings R; Heim HR; Buss AT Monogr Soc Res Child Dev; 2024 Dec; 89(3):7-109. PubMed ID: 39628288 [TBL] [Abstract][Full Text] [Related]
14. A regulatory node involving Gα Gupta S; Cooper M; Zhao X; Yarman Y; Thomson H; DeHelian D; Brass LF; Ma P J Thromb Haemost; 2023 Dec; 21(12):3633-3639. PubMed ID: 37657560 [TBL] [Abstract][Full Text] [Related]
15. Echinacoside inhibits tumor immune evasion by downregulating inducible PD-L1 and reshaping tumor immune landscape in breast and colorectal cancer. Wang X; Tan B; Liu J; Wang J; Chen M; Yang Q; Zhang X; Li F; Wei Y; Wu K; Ren G; Li H Phytomedicine; 2024 Dec; 135():156188. PubMed ID: 39488102 [TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis. Yang Y; Chen W; Dong L; Duan L; Gao P Clin Transl Oncol; 2024 Oct; 26(10):2488-2502. PubMed ID: 38625495 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I. Stephenson ZA; Harvey RF; Pryde KR; Mistry S; Hardy RE; Serreli R; Chung I; Allen TE; Stoneley M; MacFarlane M; Fischer PM; Hirst J; Kellam B; Willis AE Elife; 2020 May; 9():. PubMed ID: 32432547 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous targeting of TGF-β1/PD-L1 via a hydrogel-nanoparticle system to remodel the ECM and immune microenvironment for limiting adhesion formation. Yang QQ; Jin J; Sun J; Zhang L; Tang JB; Zhou YL Acta Biomater; 2024 Dec; 190():447-462. PubMed ID: 39481625 [TBL] [Abstract][Full Text] [Related]
19. Unlocking data: Decision-maker perspectives on cross-sectoral data sharing and linkage as part of a whole-systems approach to public health policy and practice. Tweed E; Cimova K; Craig P; Allik M; Brown D; Campbell M; Henderson D; Mayor C; Meier P; Watson N Public Health Res (Southampt); 2024 Nov; ():1-30. PubMed ID: 39582242 [TBL] [Abstract][Full Text] [Related]